The increasingly complex pharmaceutical market presents significant challenges for manufacturers executing pharmacovigilance activities:

• Vendor Overload: Managing multiple vendors across various pharmacovigilance functions, such as literature monitoring, case processing, aggregate reports, signal detection, and regulatory reporting, can lead to fragmented operations, inconsistent data quality, and increased compliance risks. This fragmentation hampers efficiency and may compromise patient safety.
• Surmounting Cost, Quality, and Timeline Challenges: Adverse event surges, global expansion, shifting regulations, and accelerated timelines raise operational costs and quality concerns.

EVERSANA’s Integrated Pharmacovigilance Solution offers a streamlined, cost-effective approach that ensures compliance by delivering fully processed adverse event cases and effective use of your product throughout its life cycle.

AI Meets Human Expertise

Our pharmacovigilance solution seamlessly integrates expert human oversight with advanced AI technologies to deliver high-quality, regulation-compliant adverse event data. By leveraging intelligent automation, we significantly accelerate case processing timelines without compromising data integrity. This empowers Marketing Authorization Holders (MAHs) to proactively manage safety risks, meet global regulatory demands, and make confident, data-driven decisions.